Analyst Ratings for [ELAN] Elanco Animal Health, Inc.

7/17/25	Upgrades	Mkt Perform Outperform	X
ELAN Elanco Animal Health Leerink Partners
$18
6/26/25	Upgrades	Mkt Perform Outperform	X
ELAN Elanco Animal Health William Blair
12/9/24	Initiated	Buy	X
ELAN Elanco Animal Health UBS
$18
12/2/24	Initiated	Market Perform	X
ELAN Elanco Animal Health Leerink Partners
$14
9/19/24	Downgrades	Overweight Eq-Weight	X
ELAN Elanco Animal Health Morgan Stanley
$17 $15
1/5/24	Upgrades	Hold Buy	X
ELAN Elanco Animal Health Stifel
$13 $20
12/19/23	Initiated	Buy	X
ELAN Elanco Animal Health Jefferies
$17
12/15/23	Upgrades	Eq-Weight Overweight	X
ELAN Elanco Animal Health Morgan Stanley
$16
12/7/23	Initiated	Outperform	X
ELAN Elanco Animal Health Exane BNP Paribas
$18
4/20/23	Upgrades	Eq Weight Overweight	X
ELAN Elanco Animal Health Barclays
$14
8/18/22	Downgrades	Overweight Eq-Weight	X
ELAN Elanco Animal Health Morgan Stanley
$37 $22
8/16/22	Downgrades	Overweight Neutral	X
ELAN Elanco Animal Health JP Morgan
$28 $24
7/12/22	Initiated	Neutral	X
ELAN Elanco Animal Health Piper Sandler
$22
11/18/21	Initiated	Overweight	X
ELAN Elanco Animal Health Morgan Stanley
$40
10/28/21	Downgrades	Buy Hold	X
ELAN Elanco Animal Health Stifel
$37 $34
6/15/21	Upgrades	Underperform Neutral	X
ELAN Elanco Animal Health Cleveland Research
5/11/21	Upgrades	Underweight Eq Weight	X
ELAN Elanco Animal Health Barclays
$25 $29
5/11/21	Upgrades	Hold Buy	X
ELAN Elanco Animal Health Gabelli & Co
4/15/21	Initiated	Buy	X
ELAN Elanco Animal Health Stifel
$37
3/22/21	Downgrades	Buy Hold	X
ELAN Elanco Animal Health Gabelli & Co
2/26/21	Upgrades	Neutral Outperform	X
ELAN Elanco Animal Health Credit Suisse
$33 $38
8/15/19	Upgrades	Sell Neutral	X
ELAN Elanco Animal Health UBS
$31 $30
5/23/19	Initiated	Neutral	X
ELAN Elanco Animal Health Guggenheim
3/18/19	Upgrades	Neutral Buy	X
ELAN Elanco Animal Health BofA/Merrill
$36
3/13/19	Resumed	Equal-Weight	X
ELAN Elanco Animal Health Morgan Stanley
$34
2/12/19	Initiated	Mkt Perform	X
ELAN Elanco Animal Health William Blair
1/23/19	Initiated	Sell	X
ELAN Elanco Animal Health UBS
$29
1/15/19	Initiated	Buy	X
ELAN Elanco Animal Health Argus
$37
10/15/18	Initiated	Neutral	X
ELAN Elanco Animal Health BofA/Merrill
$34
10/15/18	Initiated	Buy	X
ELAN Elanco Animal Health Citigroup
$37
10/15/18	Initiated	Neutral	X
ELAN Elanco Animal Health Credit Suisse
$36
10/15/18	Initiated	Neutral	X
ELAN Elanco Animal Health Goldman
$30
10/15/18	Initiated	Overweight	X
ELAN Elanco Animal Health JP Morgan
$38
10/15/18	Initiated	Equal-Weight	X
ELAN Elanco Animal Health Morgan Stanley
$35
10/12/18	Initiated	Hold	X
ELAN Elanco Animal Health Craig Hallum
9/19/18	Initiated	Buy	X
ELAN Elanco Animal Health Gabelli & Co
$32

ELAN Elanco Animal Health, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It operates through the following categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.